John Newcomb

2.4k total citations
25 papers, 1.2k citations indexed

About

John Newcomb is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, John Newcomb has authored 25 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Immunology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in John Newcomb's work include Monoclonal and Polyclonal Antibodies Research (8 papers), Glycosylation and Glycoproteins Research (5 papers) and Protein Kinase Regulation and GTPase Signaling (5 papers). John Newcomb is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (8 papers), Glycosylation and Glycoproteins Research (5 papers) and Protein Kinase Regulation and GTPase Signaling (5 papers). John Newcomb collaborates with scholars based in United States, Netherlands and Taiwan. John Newcomb's co-authors include Peter Cresswell, Peter Cresswell, Janice M. Riberdy, Xiaotian Zhu, Huilin Zhao, Joseph L. Kim, Kurt Morgenstern, Leticia M. Toledo, Paul Rose and David R. Stover and has published in prestigious journals such as Nature, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

John Newcomb

25 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Newcomb United States 15 671 481 193 173 106 25 1.2k
Ying-Bin Ouyang United States 11 349 0.5× 566 1.2× 180 0.9× 110 0.6× 116 1.1× 12 954
S Ratnofsky United States 16 702 1.0× 780 1.6× 203 1.1× 295 1.7× 65 0.6× 19 1.4k
Susan C. Howard United States 16 330 0.5× 592 1.2× 201 1.0× 124 0.7× 131 1.2× 27 999
Micah Steffek United States 16 363 0.5× 459 1.0× 142 0.7× 101 0.6× 88 0.8× 20 991
Marie Rose van Schravendijk United States 14 199 0.3× 434 0.9× 185 1.0× 123 0.7× 131 1.2× 19 768
Francis X. Sullivan United States 14 433 0.6× 1.2k 2.6× 152 0.8× 185 1.1× 260 2.5× 15 1.7k
Antonio R. Arulanandam United States 11 462 0.7× 387 0.8× 192 1.0× 149 0.9× 101 1.0× 14 805
Yu‐Hsien Chen United States 11 485 0.7× 555 1.2× 159 0.8× 240 1.4× 34 0.3× 15 954
Jeffrey D. Hulmes United States 15 276 0.4× 662 1.4× 221 1.1× 123 0.7× 55 0.5× 24 1.0k
A L DeFranco United States 18 919 1.4× 551 1.1× 288 1.5× 173 1.0× 30 0.3× 20 1.3k

Countries citing papers authored by John Newcomb

Since Specialization
Citations

This map shows the geographic impact of John Newcomb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Newcomb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Newcomb more than expected).

Fields of papers citing papers by John Newcomb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Newcomb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Newcomb. The network helps show where John Newcomb may publish in the future.

Co-authorship network of co-authors of John Newcomb

This figure shows the co-authorship network connecting the top 25 collaborators of John Newcomb. A scholar is included among the top collaborators of John Newcomb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Newcomb. John Newcomb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Newcomb, John, Ruud Ruiter, Eric Poma, et al.. (2024). Preclinical evaluation of the CD38‐targeting engineered toxin body MT‐0169 against multiple myeloma. HemaSphere. 8(11). e70039–e70039. 1 indexed citations
2.
Willert, Erin K., Jack P. Higgins, Janice Lee, et al.. (2019). Abstract 2384: TAK-169, an exceptionally potent CD38 targeted engineered toxin body, as a novel direct cell kill approach for the treatment of multiple myeloma. Cancer Research. 79(13_Supplement). 2384–2384. 14 indexed citations
3.
He, Xingyue, Jessica Riceberg, Sai Murali Krishna Pulukuri, et al.. (2015). Characterization of the Loss of SUMO Pathway Function on Cancer Cells and Tumor Proliferation. PLoS ONE. 10(4). e0123882–e0123882. 49 indexed citations
4.
Hua, Zihao, Xin Huang, Howard Bregman, et al.. (2012). 2-Phenylamino-6-cyano-1H-benzimidazole-based isoform selective casein kinase 1 gamma (CK1γ) inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(17). 5392–5395. 20 indexed citations
5.
Deak, Holly L., John Newcomb, Joseph J. Nunes, et al.. (2007). N-(3-(Phenylcarbamoyl)arylpyrimidine)-5-carboxamides as potent and selective inhibitors of Lck: Structure, synthesis and SAR. Bioorganic & Medicinal Chemistry Letters. 18(3). 1172–1176. 9 indexed citations
6.
Martin, Matthew W., John Newcomb, Joseph J. Nunes, et al.. (2007). Discovery of novel 2,3-diarylfuro[2,3-b]pyridin-4-amines as potent and selective inhibitors of Lck: Synthesis, SAR, and pharmacokinetic properties. Bioorganic & Medicinal Chemistry Letters. 17(8). 2299–2304. 28 indexed citations
7.
Newcomb, John, Benjamin Rivnay, Cecilia M. Bastos, et al.. (2003). In vitro immunomodulatory activity of ruthenium complexes. Inflammation Research. 52(6). 263–271. 13 indexed citations
8.
Zhu, Xiaotian, Joseph L. Kim, John Newcomb, et al.. (1999). Structural analysis of the lymphocyte-specific kinase Lck in complex with non-selective and Src family selective kinase inhibitors. Structure. 7(6). 651–661. 205 indexed citations
9.
Khandekar, Sanjay S., Pamela P. Brauer, Jerome W. Naylor, et al.. (1997). Affinity and kinetics of the interactions between an αβ T-cell receptor and its superantigen and class II-MHC/peptide ligands. Molecular Immunology. 34(6). 493–503. 20 indexed citations
10.
McKeever, Una, Sanjay Khandekar, Michael I. Jesson, et al.. (1997). Maternal immunization with a soluble TCR-Ig chimeric protein: long term, V beta-8 family-specific suppression of T cells by maternally transferred antibodies. The Journal of Immunology. 159(12). 5936–5945. 6 indexed citations
11.
Newcomb, John, et al.. (1996). Trimeric Interactions of the Invariant Chain and Its Association with Major Histocompatibility Complex Class II αβ Dimers. Journal of Biological Chemistry. 271(39). 24249–24256. 20 indexed citations
12.
McKeever, Una, Sanjay Khandekar, John Newcomb, et al.. (1996). Immunization with soluble BDC 2.5 T cell receptor-immunoglobulin chimeric protein:antibody specificity and protection of nonobese diabetic mice against adoptive transfer of diabetes by maternal immunization.. The Journal of Experimental Medicine. 184(5). 1755–1768. 8 indexed citations
13.
Amigorena, Sebastián, Paul Webster, James R. Drake, et al.. (1995). Invariant chain cleavage and peptide loading in major histocompatibility complex class II vesicles.. The Journal of Experimental Medicine. 181(5). 1729–1741. 129 indexed citations
14.
Newcomb, John & Peter Cresswell. (1993). Structural analysis of proteolytic products of MHC class II-invariant chain complexes generated in vivo.. The Journal of Immunology. 151(8). 4153–4163. 54 indexed citations
15.
Riberdy, Janice M., et al.. (1992). HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides. Nature. 360(6403). 474–477. 318 indexed citations
16.
Бiнек, М., et al.. (1992). Localisation of the mitogenic epitope of staphylococcal enterotoxin B. Journal of Medical Microbiology. 36(3). 155–163. 14 indexed citations
17.
Taub, Dennis D., John Newcomb, & Thomas J. Rogers. (1992). Effect of isotypic and allotypic variations of MHC class II molecules on staphylococcal enterotoxin presentation to murine T cells. Cellular Immunology. 141(2). 263–278. 20 indexed citations
18.
Newcomb, John, Yee‐Shin Lin, & Thomas J. Rogers. (1990). Requirement for accessory cells in suppression of MOPC-315 IgA secretion by staphylococcal enterotoxin B-induced T-suppressor cells. Cellular Immunology. 129(2). 528–537. 1 indexed citations
19.
Largen, Michael, et al.. (1988). Production and characterisation of monoclonal antibodies specific for staphylococcal enterotoxin B. Journal of Medical Microbiology. 27(4). 263–270. 18 indexed citations
20.
Hartnett, M. Elizabeth, John Newcomb, & Robert C. Hodson. (1987). Mutations in Chlamydomonas reinhardtii Conferring Resistance to the Herbicide Sulfometuron Methyl. PLANT PHYSIOLOGY. 85(4). 898–901. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ying-Bin Ouyang Breakdown of academic impact, for papers by S Ratnofsky Breakdown of academic impact, for papers by Susan C. Howard Breakdown of academic impact, for papers by Micah Steffek Breakdown of academic impact, for papers by Marie Rose van Schravendijk Breakdown of academic impact, for papers by Francis X. Sullivan Breakdown of academic impact, for papers by Antonio R. Arulanandam Breakdown of academic impact, for papers by Yu‐Hsien Chen Breakdown of academic impact, for papers by Jeffrey D. Hulmes Breakdown of academic impact, for papers by A L DeFranco
Rankless by CCL
2026